BiomarkersHumans
Cross validation of novel secondary executive functioning scores in the Mobile Toolbox for monitoring cognitive change
AAIC 2025 Abstract
Abstract
Background: Executive Function (EF) has multiple components (e.g., attention, inhibitory control, etc.) which can be differentially affected by AD/ADRD. Specific EF deficits can be early indicators of cognitive impairment, providing clues about etiology and likelihood of disease progression.

